Ranbaxy Out of Merck KGaA Generic Hunt; Torrent In?

Ranbaxy Laboratories is no longer in the running to buy the generic drug business of Germany's Merck, India's CNBC TV18 reported Tuesday. Ranbaxy withdrew from the second round of bidding for the business, the television station said.

Meanwhile, fellow Indian company Torrent Pharmaceuticals is teaming up with private equity firms to buy the business, the Times of India reported. Torrent made a bid of $5 billion, the Times said, citing an unnamed source.

Analysts have valued the generics unit of the drug maker at up to $6 billion, Reuters reported.

Also bidding are Israel's Teva Pharmaceutical , Iceland's Actavis and U.S. company Mylan Laboratories , according to Reuters.

Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More*

Don't Miss

U.S. Video

  • CNBC's Tyler Mathisen looks back at the week's top business and financial stories. The markets were closed for Thanksgiving, but did manage to hit new highs. Low oil prices gave consumers more money to spend for Black Friday.

  • Cyber Monday deals on Walmart's website on Dec. 2, 2013.

    CNBC's Tyler Mathisen looks ahead to what are likely to be next week's top stories. The jobs report comes out this week, as do auto sales. And the Rockefeller Center Christmas tree is lit.

  • Following last week's wild energy ride, analysts expect oil prices to continue to drop during the holiday season. CNBC's Patti Domm reports.